World's Best Scientists 2026 revealed!
Peter Bettelheim

Peter Bettelheim

D-Index & Metrics

Immunology

D-Index
52
Citations
10008
World Ranking
4058
National Ranking
40

Peter Bettelheim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter Bettelheim sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 186 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter Bettelheim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Bettelheim sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter Bettelheim is affiliated with the University of Vienna in Austria and has contributed extensively to the medical field, particularly within hematology. Their research publications primarily focus on the diagnosis and treatment of hematologic disorders using flow cytometry and molecular techniques.

The scientist has published a significant number of papers in hematology, genetics, and immunology, with a more specialized emphasis on acute myeloid leukemia and myeloproliferative neoplasms. Their work appears predominantly in recognized venues related to clinical cytometry and hematology.

Notable recent papers by Peter Bettelheim include:

  • Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues, 2022, Cytometry Part B Clinical Cytometry
  • Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet, 2021, Cytometry Part B Clinical Cytometry
  • Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group, 2021, Cytometry Part B Clinical Cytometry
  • Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDSflow working group, 2022, Cytometry Part B Clinical Cytometry
  • PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms, 2022, American Journal of Hematology

Frequent coauthors include:

  • Peter Valent
  • Matteo Giovanni Della Porta
  • Dolores Subirá
  • Theresia M. Westers
  • Frauke Bellos

Peter Bettelheim's research has been published widely in the following venues:

  • Cytometry Part B Clinical Cytometry
  • American Journal of Hematology
  • Blood
  • Leukemia
  • European Journal Of Haematology

Their publications cover main fields and subfields as follows:

  • Medicine

  • Hematology
  • Genetics
  • Immunology
  • Molecular Biology
  • Rheumatology

Main topics of research undertaken by Peter Bettelheim consist of:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Hematopoietic Stem Cell Transplantation

Best Publications

  • Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals

    Rudolf Valenta;Michael Duchêne;Karin Pettenburger;Christian Sillaber

  • Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture.

    Peter Valent;Eva Spanblochl;Wolfgang R. Sperr;Christian Sillaber

  • MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia

    Robert Pirker;Josef Wallner;Klaus Geissler;Werner Linkesch

  • Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.

    P Valent;LK Ashman;W Hinterberger;F Eckersberger

  • Interleukin-3 is a differentiation factor for human basophils.

    P Valent;G Schmidt;J Besemer;P Mayer

  • Interleukin 3 activates human blood basophils via high-affinity binding sites.

    P Valent;J Besemer;M Muhm;O Majdic

  • Cell Surface Structures on Human Basophils and Mast Cells: Biochemical and Functional Characterization

    Peter Valent;Peter Bettelheim

  • Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.

    P Bettelheim;P Valent;M Andreeff;A Tafuri

  • Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10

    M C Béné;T Nebe;P Bettelheim;B Buldini

  • The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates.

    P Mayer;P Valent;G Schmidt;E Liehl

  • Further characterization of surface membrane structures expressed on human basophils and mast cells.

    Peter Valent;Otto Majdic;Dieter Maurer;Michael Bodger

  • Expression of a myeloid marker on TdT-positive acute lymphocytic leukemic cells: evidence by double-fluorescence staining.

    P Bettelheim;E Paietta;O Majdic;H Gadner

  • M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells.

    Otto Majdic;Peter Bettelheim;Hannes Stockinger;Werner Aberer

  • VIL-A1, A monoclonal antibody reactive with common acute lymphatic leukemia cells

    Walter Knapp;Otto Majdic;Peter Bettelheim;Kristof Liszka

  • IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.

    C Sillaber;H Strobl;D Bevec;L K Ashman

  • Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor.

    Klaus Geissler;Peter Valent;Peter Mayer;Ekke Liehl

  • Interleukin 4 promotes expression of mast cell ICAM-1 antigen.

    P Valent;D Bevec;D Maurer;J Besemer

  • Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia

    I Schwarzinger;P Valent;U Köller;C Marosi

  • Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia

    P. Bettelheim;D. Lutz;O. Majdic;E. Paietta

  • Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.

    Mayer P;Geissler K;Valent P;Ceska M

Frequent Co-Authors

Peter Valent
Peter Valent Medical University of Vienna
Klaus Lechner
Klaus Lechner Medical University of Vienna
Walter Knapp
Walter Knapp University of Vienna
Otto Majdic
Otto Majdic University of Vienna
Oskar A. Haas
Oskar A. Haas Medical University of Vienna
Ulrich Germing
Ulrich Germing Heinrich Heine University Düsseldorf
Hannes Stockinger
Hannes Stockinger Medical University of Vienna
Wolfgang Kern
Wolfgang Kern Munich Leukemia Laboratory (Germany)
Andreas Chott
Andreas Chott Medical University of Vienna
Thomas Rülicke
Thomas Rülicke University of Veterinary Medicine Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals start with foundational roles such as Licensed Practical Nurses (LPNs), where several lpn schools easy to get into offer accessible entry points and flexible online formats. These programs provide essential clinical skills applicable in immunology-focused settings.

Advancing in the nursing field, becoming a Nurse Practitioner (NP) is a popular step. Students often seek the easiest np programs to get into that balance rigorous education with attainable admissions. Such programs prepare graduates for specialized immunological patient care and treatment roles.

There is also growing demand for Psychiatric Mental Health Nurse Practitioners (PMHNPs), especially those trained online. Programs with the top psychiatric mental health nurse practitioner programs online are designed to provide the best clinical placement experiences, which are vital for hands-on psychiatric and immunological practice integration.

Cost is a significant factor for many prospective students. Accessing the cheapest psych np programs online can make pursuing advanced healthcare degrees more attainable without compromising quality, ultimately supporting long-term career development in immunology-related fields.

Best Scientists Citing Peter Bettelheim

Trending Scientists

Recently Published Articles